ZEGERID
MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE
Approval overview ZEGERID is listed in Drugs@FDA under application 021850 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE Form and strength TABLET, CHEWABLE;ORAL - 700MG;40MG;600MG Sponsor SANTARUS Submission history Latest submission status date: 2010-09-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZEGERID is listed in Drugs@FDA under application 021850 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE Form and strength TABLET, CHEWABLE;ORAL - 700MG;40MG;600MG Sponsor SANTARUS Submission history Latest submission status date: 2010-09-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.